Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease.

Björkegren J, Boquist S, Samnegârd A, Lundman P, Tornvall P, Ericsson CG, Hamsten A.

Circulation. 2000 Jan 25;101(3):227-30.

2.

Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.

Björkegren J, Silveira A, Boquist S, Tang R, Karpe F, Bond MG, de Faire U, Hamsten A.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1470-4.

5.

Alterations of VLDL composition during alimentary lipemia.

Björkegren J, Hamsten A, Milne RW, Karpe F.

J Lipid Res. 1997 Feb;38(2):301-14.

6.

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.

Metabolism. 2000 Aug;49(8):1049-54.

PMID:
10954025
7.

Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.

Jackson KG, Wolstencroft EJ, Bateman PA, Yaqoob P, Williams CM.

Nutr Metab Cardiovasc Dis. 2006 Sep;16(6):405-17.

PMID:
16935699
8.

Postprandial remnant-like lipoproteins in hypertriglyceridemia.

Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE.

J Clin Endocrinol Metab. 2001 Jul;86(7):3134-42.

PMID:
11443178
9.
10.
11.

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Hiukka A, Fruchart-Najib J, Leinonen E, Hilden H, Fruchart JC, Taskinen MR.

Diabetologia. 2005 Jun;48(6):1207-15.

PMID:
15864534
12.

Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.

Granér M, Kahri J, Nakano T, Sarna SJ, Nieminen MS, Syvänne M, Taskinen MR.

Eur J Clin Invest. 2006 Nov;36(11):764-70.

PMID:
17032343
13.

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.

Boquist S, Karpe F, Danell-Toverud K, Hamsten A.

Atherosclerosis. 2002 May;162(1):163-70.

PMID:
11947910
14.
15.

Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.

Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G.

Lipids. 2001 Oct;36(10):1117-24.

PMID:
11768156
17.

Postprandial hyperlipidemia and remnant lipoproteins.

Havel RJ.

Curr Opin Lipidol. 1994 Apr;5(2):102-9. Review.

PMID:
8044412
18.

The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.

Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, Björkegren J.

J Am Coll Cardiol. 2005 Apr 5;45(7):1013-7.

19.

Impaired postprandial clearance of squalene and apolipoprotein B-48 in post-menopausal women with coronary artery disease.

Rajaratnam RA, Gylling H, Miettinen TA.

Clin Sci (Lond). 1999 Aug;97(2):183-92.

PMID:
10409473
20.

Atherogenicity of triglyceride-rich lipoproteins.

Krauss RM.

Am J Cardiol. 1998 Feb 26;81(4A):13B-17B.

PMID:
9526808
Items per page

Supplemental Content

Support Center